Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by desolationsoundon Mar 07, 2015 1:14am

206 Views

Post# 23499774

RE:RJC7 Well thought out post

That is one way to increase SP = get more investors
I realised you cut and pasted the info from the conference website,
Low trade volumes - we could be churning in mid-low 50 cent range for next 3-4 months
Unless we get some results like positive news releases - or if we have more stock dilution announcements I think the SP could dip into the 40 cent range (which I hope the mgmt team is not contemplating doing more of right now)
I am selling off some positions and keeping my postions in my RRSP account as I think we may not see the SP increases we saw in 2014 IMHO

Bullboard Posts

Catching up with one of the busiest junior gold developers